62 results
424B3
BIAF
bioAffinity Technologies, Inc.
23 Sep 24
Prospectus supplement
4:00pm
revenues.
Our employees, consultants, partners, and vendors may engage in misconduct or other improper activities.
Failure to comply with healthcare fraud … , directly or indirectly, to federal and state healthcare fraud and abuse laws, false claims laws, health information privacy and security laws, and other
424B3
BIAF
bioAffinity Technologies, Inc.
14 Aug 24
Prospectus supplement
4:19pm
, process, summarize and report financial information; and
Any fraud, whether or not material, that involves management or other employees who have … ; and
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
424B3
BIAF
bioAffinity Technologies, Inc.
14 Aug 24
Prospectus supplement
4:19pm
the registrant’s ability to record, process, summarize and report financial information; and
Any fraud, whether or not material, that involves management or other … financial information; and
Any fraud, whether or not material, that involves management or other employees who have a significant role
D
fra9j0s bjfev
12 Aug 24
$1.30 mm in equity / options / securities to be acquired, sold $1.30 mm, 3 investors
4:00pm
D
36qq mhc6hvu8x
12 Aug 24
$450.00 k in equity / options / securities to be acquired, sold $450.00 k, 3 investors
4:00pm
8-K
EX-10.1
tmo3z273c cum3
5 Aug 24
Entry into a Material Definitive Agreement
9:03am
8-K
EX-1.1
0xmdc4p
5 Aug 24
Entry into a Material Definitive Agreement
9:03am
424B5
m87aio6k1ni56io1h91t
5 Aug 24
Prospectus supplement for primary offering
9:00am
424B3
wk518x6 ma2
22 May 24
Prospectus supplement
4:00pm
424B3
0eaae gwulldbo0o
22 May 24
Prospectus supplement
4:00pm
424B3
njffkhq69
16 Apr 24
Prospectus supplement
7:19pm
POS AM
j7sy9c
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm